Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5467 studies found for:    vaccination
Show Display Options
Rank Status Study
21 Recruiting Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Conditions: HPV16+;   Cervical Intraepithelial Neoplasia (CIN 2/3)
Interventions: Biological: DNA vaccination;   Device: Gene gun vaccine;   Biological: intramuscular vaccination;   Biological: intra-lesional vaccine administration;   Procedure: therapeutic resection of the lesion;   Drug: imiquimod
22 Completed Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine
Conditions: Rabies;   Rabies Virus
Interventions: Biological: Purified inactivated rabies vaccine, serum free;   Biological: Purified Vero Rabies Vaccine
23 Completed
Has Results
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults
Condition: Influenza
Interventions: Biological: Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),;   Biological: Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),;   Biological: Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)
24 Completed The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases
Conditions: Coronary Artery Diseases;   Myocardial Infarction;   Stable Angina
Interventions: Biological: influenza vaccine;   Biological: placebo for influenza vaccine
25 Recruiting Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer
Conditions: Lung Cancer;   Adenocarcinoma
Interventions: Biological: GM.CD40L.CCL21 Vaccinations;   Biological: GM.CD40L cells Vaccinations
26 Completed Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated dengue serotype 1, 2, 3, and 4 virus;   Biological: Yellow fever vaccine;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal Conjugated Vaccine;   Biological: Hepatitis A Pediatric Vaccine;   Biological: Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine;   Biological: Yellow Fever Vaccine;   Biological: Placebo (NaCl)
27 Completed Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents
Condition: Influenza
Interventions: Biological: Seasonal Influenza DNA vaccine;   Biological: TIV
28 Active, not recruiting High-Dose Influenza Vaccine in Nursing Homes
Condition: Influenza
Interventions: Biological: HD Vaccine;   Biological: SD Vaccine;   Biological: Free Staff Vaccine;   Biological: No Free Staff Vaccine
29 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
30 Completed Direct and Indirect Protection by Influenza Vaccine Given to Children in India
Condition: Influenza
Interventions: Biological: Inactivated Trivalent Influenza Vaccine;   Biological: Inactivated polio vaccine (IPV)
31 Completed Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children
Conditions: Hand-foot-mouth Disease;   Infection; Viral, Enterovirus
Interventions: Biological: 100U inactivated Enterovirus Type 71 Vaccine;   Biological: 200U inactivated Enterovirus Type 71 Vaccine;   Biological: 400U inactivated Enterovirus Type 71 Vaccine;   Biological: Placebo
32 Completed Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Conditions: Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Test Vaccine;   Biological: US Licensed Vaccine
33 Recruiting Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: CYD Dengue and Japanese Encephalitis Vaccines;   Biological: Japanese Encephalitis and CYD Dengue Vaccines
34 Completed Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults
Condition: Hepatitis A
Interventions: Biological: Inactivated HAV vaccine;   Biological: Live attenuated HAV vaccine
35 Active, not recruiting Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine
Condition: Poliomyelitis
Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV);   Biological: Trivalent Oral Polio Vaccine (tOPV);   Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2);   Biological: Sanofi-Pasteur IPV (Sanofi IPV);   Biological: Glaxo SmithKline IPV (GSK IPV);   Biological: Serum Institute of India IPV (SII IPV)
36 Completed Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Condition: Plague Vaccine
Interventions: Biological: rF1V vaccine (with Adjuvant);   Biological: rF1V vaccine (without Adjuvant)
37 Completed
Has Results
Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
Condition: HIV Infections
Interventions: Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccination
38 Completed
Has Results
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Conditions: Hepatitis B;   Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A;   Biological: Prevenar;   Biological: Infanrix hexa;   Biological: Infanrix IPV Hib;   Biological: Infanrix penta;   Biological: Infanrix IPV;   Biological: Meningitec;   Biological: NeisVac-C;   Biological: Menitorix
39 Completed Efficacy Study of T Cell Vaccination in HIV Infection
Condition: HIV Infections
Intervention: Biological: T cell vaccination
40 Recruiting Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study
Condition: Non Resectable Stage III or Stage IV Malignant Melanoma
Interventions: Other: Intradermal Autologous DC Vaccine + RT;   Other: Intradermal Autologous DC Vaccine + IFN-alfa;   Other: Intradermal Autologous Dendritic Cell Vaccine + radiotherapy + IFN-alfa;   Biological: only Intradermal Autologous DC Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years